从资金流向上来看，当日医疗美容板块主力资金净流入1124.53万元，游资资金净流出4843.84万元，散户 资金净流入3719.31万元。医疗美容板块个股资金流向见下表： 证券之星消息，8月25日医疗美容板块较上一交易日上涨0.48%，华熙生物领涨。当日上证指数报收于 3883.56，上涨1.51%。深证成指报收于12441.07，上涨2.26%。医疗美容板块个股涨跌见下表： | 代码 | | | 名称 ｜主力净流入（元）｜主力净占比｜游资净流入（元）｜游资净占比｜散户净流入（元）｜散户净占比 | | | | | --- | --- | --- | --- | --- | --- | --- | | 300896 爱美客 | 572.73万 | 0.57% | -3609.35万 | -3.59% | 3036.62万 | 3.02% | | 688363 华熙生物 | 478.82万 | 1.20% | -1069.13万 | -2.69% | 590.30万 | 1.48% | | 000615 *ST美谷 | 72.97万 | 2.59% | -165.36万 | -5.87% | 92.38万 | 3 ...

Group 1 - The core viewpoint of the article highlights the fluctuating investment and financing trends in China's medical beauty industry, with a peak in 2016 and a decline thereafter [1][17] - Investment events peaked in 2016 with 19 occurrences and an investment amount of 1.353 billion RMB, while the highest investment amount was recorded in 2018 at 2.374 billion RMB [1] - By 2024, only 3 investment events occurred with a total investment of 150 million RMB, and as of June 5, 2025, only 1 event with an investment of 30 million RMB was reported [1] Group 2 - The majority of investment rounds in the medical beauty industry are concentrated in early stages, particularly angel and A-round financing [2] - The industry encompasses various fields such as medical beauty raw materials, equipment, and service platforms, indicating strong innovation and technical barriers [2] Group 3 - Investment activities are primarily concentrated in Beijing and Guangdong, with 49 and 23 financing events respectively, followed by Sichuan and Shanghai with 12 and 9 events [4] - The focus on these regions is attributed to the concentration of resources and opportunities in the medical beauty sector [4] Group 4 - The investment direction is primarily focused on the construction of medical beauty platforms [6] Group 5 - The main investment entities in the medical beauty industry are capital organizations, accounting for 73% of the total, while industrial entities like Gree Electric and Xiaomi Group make up 27% [5] Group 6 - There are few industry investment funds specifically targeting medical beauty, with only 2 private funds identified [13] Group 7 - Recent years have seen a trend of horizontal acquisitions among midstream enterprises in the medical beauty industry as a means to expand scale [15] - Notable acquisition events include 康哲药业 acquiring 旭俐医疗 with a 100% stake and 新氧 acquiring 奇致激光 [16] Group 8 - Overall, the investment and financing landscape in China's medical beauty industry has shown fluctuations, with a concentration of activities in Beijing and Guangdong, primarily driven by capital investment institutions [17]

奥园美谷科技股份有限公司 证券代码：000615 证券简称：*ST美谷 公告编号：2025-072 公司对此次调整定期报告披露时间给投资者带来的不便致以诚挚的歉意，敬 请广大投资者谅解。 奥园美谷科技股份有限公司 关于延期披露 2025 年半年度报告的公告 董事会 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 二〇二五年八月二十二日 奥园美谷科技股份有限公司（以下简称"公司"）原定于 2025 年 8 月 26 日披露《2025 年半年度报告》，为进一步完善半年度报告编制和复核的相关工 作，确保半年度报告披露的真实性、准确性和完整性，基于谨慎考虑，经向深圳 证券交易所申请，公司将《2025 年半年度报告》的披露时间延期至 2025 年 8 月 28 日。 1 公司指定的信息披露媒体为《证券时报》和巨潮资讯网（www.cninfo.com.cn）， 有关信息均以公司在前述指定媒体刊登的公告为准，敬请广大投资者谨慎决策， 注意投资风险。 特此公告。 ...

奥园美谷科技股份有限公司 关于新增诉讼和仲裁的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次案件所处的阶段：立案受理； 证券代码：000615 证券简称：*ST美谷 公告编号：2025-071 （一）诉讼案件基本情况 2、所处的当事人地位：被告、被申请人； 3、案件涉案金额：约 6,000.65 万元（诉讼）、约 444.67 万元（仲裁）； 4、对上市公司损益产生的影响：公司将根据企业会计准则的相关规定和案 件等情况进行财务处理，具体处理结果以及对公司本期期末业绩的影响，以会计 师事务所最终年度审计结果为准； 5、敬请广大投资者关注风险提示内容，谨慎决策、注意投资风险。 奥园美谷科技股份有限公司（以下简称"公司""奥园美谷"）于近日收到 杭州市上城区人民法院送达的传票和应诉通知书，具体诉讼情况如下： 一、本次案件的基本情况 1、案由 融资租赁合同纠纷 受理法院：杭州市上城区人民法院，案号：（2025）浙 0102 民初 20470 号 2、案件原告和被告 （2）判令被告一向原告支付合同编号为 ZY2021SH0178 的《融资租赁 ...

奥园美谷科技股份有限公司 关于控股子公司债务逾期的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 证券代码：000615 证券简称：*ST美谷 公告编号：2025-070 一、控股子公司债务逾期情况概述 奥园美谷科技股份有限公司（以下简称"公司"）控股子公司湖北金环绿色 纤维有限公司（以下简称"金环绿纤"）、湖北金环新材料科技有限公司（以下 简称"金环新材料"）和广州奥美产业投资有限公司（以下简称"奥美产投"） 出现部分债务未能如期偿还的情形，公司及其控股子公司对前述逾期债务提供了 连带责任担保，具体详见 2024 年 11 月 28 日、2025 年 1 月 10 日、2 月 6 日、2 月 18 日、3 月 8 日、3 月 22 日、5 月 21 日、6 月 24 日和 7 月 12 日刊登在巨潮 资讯网（www.cninfo.com.cn，下同）的《关于控股子公司债务逾期的公告》（公 告编号：2024-116）、《关于控股子公司债务逾期的公告》（公告编号：2025-002）、 《关于控股子公司债务逾期的进展公告》（公告编号：2025-006）、 ...

Market Performance - The medical beauty sector increased by 1.03% on August 18, with Jinbo Biological leading the gains [1] - The Shanghai Composite Index closed at 3728.03, up 0.85%, while the Shenzhen Component Index closed at 11835.57, up 1.73% [1] Individual Stock Performance - Jinbo Biological (832982) closed at 308.46, with a rise of 3.60% and a trading volume of 16,000 shares [1] - Aimeike (300896) closed at 183.87, up 1.09% with a trading volume of 43,400 shares [1] - Huaxi Biological (688363) closed at 53.84, increasing by 1.01% with a trading volume of 49,300 shares [1] - *ST Meigu (000615) closed at 3.21, up 0.31% with a trading volume of 107,200 shares [1] Capital Flow Analysis - The medical beauty sector experienced a net outflow of 7.81 million yuan from main funds, while retail funds saw a net outflow of 22.98 million yuan [1] - Speculative funds had a net inflow of 30.79 million yuan [1] Detailed Capital Flow for Individual Stocks - Aimeike (300896) had a main fund net inflow of 15.99 million yuan, with a retail net outflow of 34.19 million yuan [2] - *ST Meigu (000615) saw a main fund net inflow of 0.25 million yuan, with a retail net outflow of 1.13 million yuan [2] - Huaxi Biological (688363) experienced a main fund net outflow of 24.06 million yuan, while retail funds had a net inflow of 1.23 million yuan [2]

Market Overview - The medical beauty sector experienced a decline of 0.21% on August 13, with Jinbo Biological leading the drop [1] - The Shanghai Composite Index closed at 3683.46, up 0.48%, while the Shenzhen Component Index closed at 11551.36, up 1.76% [1] Individual Stock Performance - ST Meigu closed at 3.15 with no change, trading volume of 88,100 shares, and a transaction value of 27.62 million yuan [1] - Huaxi Biological closed at 53.60, down 0.09%, with a trading volume of 40,900 shares and a transaction value of 218 million yuan [1] - Aimeike closed at 186.00, down 0.29%, with a trading volume of 32,400 shares and a transaction value of 600 million yuan [1] - Jinbo Biological closed at 301.49, down 0.49%, with a trading volume of 8,955 shares and a transaction value of 271 million yuan [1] Capital Flow Analysis - The medical beauty sector saw a net outflow of 63.94 million yuan from institutional investors, while retail investors had a net inflow of 61.61 million yuan [1] - Speculative funds recorded a net inflow of 2.34 million yuan [1] Additional Stock Data - ST Meigu reported a net outflow of 3.73 million yuan, a decrease of 13.52% [2] - Huaxi Biological had a net outflow of 16.99 million yuan, a decrease of 7.78% [2] - Aimeike experienced a net outflow of 43.22 million yuan, a decrease of 7.20% [2]

Group 1 - The medical beauty sector increased by 0.16% on August 6, with Jinbo Biological leading the gains [1] - The Shanghai Composite Index closed at 3633.99, up 0.45%, while the Shenzhen Component Index closed at 11177.78, up 0.64% [1] - Key stocks in the medical beauty sector showed varied performance, with Jinbo Biological closing at 328.28, up 0.90%, and Aimeike slightly down by 0.03% [1] Group 2 - The medical beauty sector experienced a net outflow of 171.11 thousand yuan from main funds, while retail funds saw a net outflow of 668.85 thousand yuan [1] - The table indicates that *ST Meigu had a main fund inflow of 145.78 thousand yuan but a significant outflow from retail investors [2] - Huaxi Biological and Aimeike also showed mixed fund flows, with Huaxi experiencing a net outflow from main funds and a small inflow from retail investors [2]

证券代码：000615 证券简称：*ST美谷 公告编号：2025-069 奥园美谷科技股份有限公司 关于公司收到债权及担保权利转让暨催收通知的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 奥园美谷科技股份有限公司（以下简称"公司"）于 2025 年 7 月 30 日收到 中国民生银行股份有限公司广州分行（以下简称"民生银行""转让方"）和中 国信达资产管理股份有限公司广东省分公司（以下简称"信达资管""受让方"） 出具的《债权及担保权利转让暨催收通知》（（2025）民生信达粤 03 号），现 将相关事项公告如下： 一、债权及担保权利转让与催收通知的主要内容 根据中国民生银行股份有限公司广州分行与中国信达资产管理股份有限公 司广东省分公司达成的资产转让协议，转让方将其对下文清单所列借款人及其担 保人享有的主债权及借款合同、担保合同等其他相关协议项下的全部权利，依法 转让给受让方。 现转让方及受让方共同以邮寄送达的方式通知各借款人、担保人以及借款人、 担保人因各种原因发生更名、改制、歇业、吊销营业执照或丧失民事主体资格等 情况的相关承债主体或清算主体上述债 ...

Group 1 - The medical beauty sector experienced a decline of 0.17% on July 29, with Ai Meike leading the drop [1] - The Shanghai Composite Index closed at 3609.71, up 0.33%, while the Shenzhen Component Index closed at 11289.41, up 0.64% [1] - Major stocks in the medical beauty sector showed mixed performance, with Jinbo Biological up 1.82% and Ai Meike down 0.73% [1] Group 2 - The medical beauty sector saw a net outflow of 37.97 million yuan from main funds, while retail investors contributed a net inflow of 56.99 million yuan [1] - Specific stock performances included Huaxi Biological with a net outflow of 1.47 million yuan and *ST Meigu with a net inflow of 0.55 million yuan [2]